US Economy U.S. News

More

Contact U.S. News

  • CNBC NEWSLETTERS

    Get the best of CNBC in your inbox

    Please choose a subscription

    Please enter a valid email address
    Get these newsletters delivered to your inbox, and more info about about our products and service. Privacy Policy.

Don't Miss

U.S. Video

  • Futures Now: Gold shines

    The Futures Now team discusses what factors are supporting gold, with Jeff Kilburg, KKM Financial, and Anthony Grisanti, GRZ Energy president.

  • Top fund manager on health care

    Joe Edelman, Perceptive Advisors CEO, shares his outlook for the biotech and health care sectors, and the risk/reward with high drug prices.

  • Showdown over Sarepta's muscular dystrophy drug

    Joe Edelman, Perceptive Advisors CEO, is a Sarepta shareholder and believes the company's experimental drug in clinical trials "eteplirsen" will be approved by the FDA. The drug is proposed to treat Duchenne muscular dystrophy.